A philosophical look at market turn in the Age of AI, with John Holodnak
Today, the life sciences sector is prioritising recruitment of leaders who can scale efficiently in capital-constrained environments, as well as focusing on hybrid operator-strategists who can integrate AI into R&D, clinical, and commercial workflows.
In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with John Holodnak, co-founder of Occam, about how AI is beginning to reshape career paths across life sciences.
Holodnak discusses AI’s transformation of functional roles in life sciences, such as regulatory, market access, and business development, and explores the breakdown of linear career paths and way ahead for biotech and pharma professionals tomorrow.
You can listen to episode 257 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
